The evidence brought forth by this work via multiple distinct assays, which span in vitro and in vivo systems, shows positive, dose-dependent, statistically significant effects of the HGF positive modulator ATH-1105 in ALS-relevant disease models. This evidence concerns the gene HGF and amyotrophic lateral sclerosis.